Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Hospira“
Suchtreffer
Begriffe & Kennungen
Topotecan Hospira · 4.8 · Haematological
Eintrag öffnenTopotecan Hospira · 4.8 · Hypersensitivity reactions including rash, urticaria, angioedema and anaphylactic reactions have been reported
Eintrag öffnenTopotecan Hospira · 4.8 · In dose-finding studies involving 523 patients with relapsed ovarian cancer and 631 patients with relapsed sma
Eintrag öffnenTopotecan Hospira · 4.8 · Infections and infestations Very common Infection Common Sepsis1 Blood and lymphatic system disorders Very com
Eintrag öffnenTopotecan Hospira · 4.8 · Mild abdominal pain was reported in 4% of patients.
Eintrag öffnenTopotecan Hospira · 4.8 · Neutropenia Severe (neutrophil count <0.5 x 109/l) during course 1 in 55% of patients, with duration ≥seven da
Eintrag öffnenTopotecan Hospira · 4.8 · Other severe events that were recorded as related or possibly related to topotecan treatment were anorexia (12
Eintrag öffnenTopotecan Hospira · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenTopotecan Hospira · 4.8 · The adverse events listed above have the potential to occur with a higher frequency in patients who have a poo
Eintrag öffnenTopotecan Hospira · 4.8 · The frequencies associated with the haematological and non-haematological adverse events listed below represen
Eintrag öffnenTopotecan Hospira · 4.8 · The integrated safety data for topotecan monotherapy are presented below.
Eintrag öffnenTopotecan Hospira · 4.8 · The safety profile of topotecan when given in combination with cisplatin in the cervical cancer clinical studi
Eintrag öffnenTopotecan Hospira · 4.8 · Thrombocytopenia Severe (platelets <25 x 109/l) in 25% of patients (8% of courses); moderate (platelets betwee
Eintrag öffnenTopotecan Hospira · 4.8 · Total or pronounced alopecia was observed in 30% of patients and partial alopecia in 15% of patients.
Eintrag öffnenTopotecan Hospira · 4.8 · Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
Eintrag öffnenVoriconazole Hikma (previously Voriconazole Hospira)
Eintrag öffnenVoriconazole Hikma (previously Voriconazole Hospira) · 4.1 Therapeutic indications · 1
Eintrag öffnenVoriconazole Hikma (previously Voriconazole Hospira) · 4.3 Contraindications · 1
Eintrag öffnenVoriconazole Hikma (previously Voriconazole Hospira) · 4.3 · Coadministration of voriconazole is contraindicated with medicinal products that are highly dependent on CYP3A
Eintrag öffnenVoriconazole Hikma (previously Voriconazole Hospira) · 4.3 · Coadministration of voriconazole is contraindicated with medicinal products that induce CYP3A4 and significant
Eintrag öffnen